Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.
Antios Therapeutics is a biopharmaceutical company devoted to developing innovative therapies for viral diseases. With an experienced and proven leadership team, the company is focused on the development of its oral drug candidate for potentially curative treatment of HBV infections.Antios Therapeutics was founded by Abel De La Rosa, Douglas Mayers, and Idean Marvasty.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 3, 2021 | Series B | $75M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Heartland Healthcare Capital | — | Series B |
Avego Bioscience Capital | — | Series B |